113
Views
24
CrossRef citations to date
0
Altmetric
Review

Genetics of Parkinson’s disease and parkinsonism

, &
Pages 657-666 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Elena Miñones-Moyano, Marc R. Friedländer, Joan Pallares, Birgit Kagerbauer, Sílvia Porta, Georgia Escaramís, Isidre Ferrer, Xavier Estivill & Eulàlia Martí. (2013) Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction. RNA Biology 10:7, pages 1093-1106.
Read now
Michael R Douglas. (2013) Gene therapy for Parkinson’s disease: state-of-the-art treatments for neurodegenerative disease. Expert Review of Neurotherapeutics 13:6, pages 695-705.
Read now
Miao Cai, Jun Tian, Guo-hua Zhao, Wei Luo & Bao-rong Zhang. (2011) Study of Methylation Levels of Parkin Gene Promoter in Parkinson's Disease Patients. International Journal of Neuroscience 121:9, pages 497-502.
Read now
Roberto Santucci, Federica Sinibaldi, Antonella Patriarca, Daniele Santucci & Laura Fiorucci. (2010) Misfolded proteins and neurodegeneration: role of non-native cytochrome c in cell death. Expert Review of Proteomics 7:4, pages 507-517.
Read now
George R. Uhl, Tomas Drgon, Catherine Johnson & Qing-Rong Liu. (2009) Addiction Genetics and Pleiotropic Effects of Common Haplotypes that Make Polygenic Contributions to Vulnerability to Substance Dependence. Journal of Neurogenetics 23:3, pages 272-282.
Read now
I. S. Pienaar, L. A. Kellaway, V. A. Russell, A. D. Smith, D. J. Stein, M. J. Zigmond & W. M. U. Daniels. (2008) Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: Implications for neurodegenerative disorders. Stress 11:6, pages 448-456.
Read now

Articles from other publishers (17)

Gian Pal, Lola Cook, Jeanine Schulze, Jennifer Verbrugge, Roy N. Alcalay, Marcelo Merello, Carolyn M. Sue, Soraya Bardien, Vincenzo Bonifati, Sun Ju Chung, Tatiana Foroud, Emilia Gatto, Anne Hall, Nobutaka Hattori, Tim Lynch, Karen Marder, Deborah Mascalzoni, Ivana Novaković, Avner Thaler, Deborah Raymond, Mehri Salari, Ali Shalash, Oksana Suchowersky, Niccolò E. Mencacci, Tanya Simuni, Rachel Saunders‐Pullman & Christine Klein. (2023) Genetic Testing in Parkinson's Disease. Movement Disorders 38:8, pages 1384-1396.
Crossref
Saima Owais & Yasir Hasan Siddique. (2023) A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches. CNS & Neurological Disorders - Drug Targets 22:3, pages 353-380.
Crossref
Lamei Yuan, Xiangyu Chen, Zhi Song, Weidong Le, Wen Zheng, Xin Liu & Hao Deng. (2020) Extended Study of NUS1 Gene Variants in Parkinson's Disease. Frontiers in Neurology 11.
Crossref
Amy R. Dunn, Kristen M.S. O’Connell & Catherine C. Kaczorowski. (2019) Gene-by-environment interactions in Alzheimer’s disease and Parkinson’s disease. Neuroscience & Biobehavioral Reviews 103, pages 73-80.
Crossref
Shamsuzzama, Lalit Kumar & Aamir Nazir. (2017) Modulation of Alpha-synuclein Expression and Associated Effects by MicroRNA Let-7 in Transgenic C. elegans. Frontiers in Molecular Neuroscience 10.
Crossref
Lilach Soreq, Alessandro Guffanti, Nathan Salomonis, Alon Simchovitz, Zvi Israel, Hagai Bergman & Hermona Soreq. (2014) Long Non-Coding RNA and Alternative Splicing Modulations in Parkinson's Leukocytes Identified by RNA Sequencing. PLoS Computational Biology 10:3, pages e1003517.
Crossref
Lance M. Bollinger, Celsi E. Cowan & Thomas P. LaFontaine. (2012) Parkinson's Disease. Strength & Conditioning Journal 34:2, pages 50-54.
Crossref
Rachel Denyer & Michael R. Douglas. (2012) Gene Therapy for Parkinson's Disease. Parkinson's Disease 2012, pages 1-13.
Crossref
Elena Miñones-Moyano, Sílvia Porta, Georgia Escaramís, Raquel Rabionet, Susana Iraola, Birgit Kagerbauer, Yolanda Espinosa-Parrilla, Isidre Ferrer, Xavier Estivill & Eulàlia Martí. (2011) MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Human Molecular Genetics 20:15, pages 3067-3078.
Crossref
Oswaldo Lorenzo-Betancor, Lluís Samaranch, Elena García-Martín, Sebastián Cervantes, José A.G. Agúndez, Félix J. Jiménez-Jiménez, Hortensia Alonso-Navarro, Antonio Luengo, Francisco Coria, Elena Lorenzo, Jaione Irigoyen & Pau Pastor. (2011) LINGO1 gene analysis in Parkinson's disease phenotypes . Movement Disorders 26:4, pages 722-727.
Crossref
Donglai Sheng, Dianbo Qu, Ken Hon Hung Kwok, Seok Shin Ng, Adrian Yin Ming Lim, Sharon Siqi Aw, Charlie Wah Heng Lee, Wing Kin Sung, Eng King Tan, Thomas Lufkin, Suresh Jesuthasan, Mathavan Sinnakaruppan & Jianjun Liu. (2010) Deletion of the WD40 Domain of LRRK2 in Zebrafish Causes Parkinsonism-Like Loss of Neurons and Locomotive Defect. PLoS Genetics 6:4, pages e1000914.
Crossref
Derya R. Shimshek, Matthias Mueller, Christoph Wiessner, Tatjana Schweizer & P. Herman van der Putten. (2010) The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy. PLoS ONE 5:4, pages e10014.
Crossref
George R. Uhl, Tomas Drgon, Catherine Johnson & Qing-Rong Liu. 2011. Addiction Medicine. Addiction Medicine 201 223 .
George R. Uhl, Tomas Drgon, Catherine Johnson, Chuan-Yun Li, Carlo Contoreggi, Judith Hess, Daniel Naiman & Qing-Rong Liu. (2008) Molecular Genetics of Addiction and Related Heritable Phenotypes. Annals of the New York Academy of Sciences 1141:1, pages 318-381.
Crossref
Marie-Francoise Chesselet, Sheila Fleming, Farzad Mortazavi & Bernd Meurers. (2008) Strengths and limitations of genetic mouse models of Parkinson's disease. Parkinsonism & Related Disorders 14, pages S84-S87.
Crossref
Marie-Francoise Chesselet & Pierre-Olivier Fernagut. 2008. Parkinson's Disease. Parkinson's Disease 285 294 .
Edith G McGeer & Patrick L McGeer. (2007) The Role of Anti-Inflammatory Agents in Parkinson???s Disease. CNS Drugs 21:10, pages 789-797.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.